Affiliation:
1. Department of Child & Adolescent Psychiatry (SGDP P046), King’s College London Institute of Psychiatry, De Crespigny Park, London SE5 8AZ, UK
Abstract
There is much more to successful drug treatment than writing a prescription. In this article, we describe some of the ‘holistic’ aspects of the pharmacological treatment of attention deficit–hyperactivity disorder, with an emphasis on helping families to decide between psychological and pharmacological treatment and on the process of psychoeducation. Detailed accounts of drug and behavioral treatment in various circumstances are available elsewhere; however, the value and process of psychoeducation is sometimes underestimated or referred to in a cursory statement of the need for a good doctor–patient relationship. There has been little in the way of controlled trials, so no meta-analysis is attempted. Where possible (e.g., in reviewing the effects of psychological therapy and prediction of drug response), PubMed/Medline was searched for systematic reviews and randomized trials, but this article’s conclusions should be taken as personal. These subjective views are based chiefly on experience in clinical practice, participation in focus groups with young people and their families and work with support groups.
Subject
Neurology (clinical),Neurology
Reference55 articles.
1. Developing ADHD
2. European clinical guidelines for hyperkinetic disorder ? first upgrade
3. Long-acting medications for the hyperkinetic disorders
4. National Institute for Health and Clinical Excellence (NICE):Attention Deficit Hyperactivity Disorder. Diagnosis and Management of ADHD in Children, Young People and Adults. The British Psychological Society and The Royal College of Psychiatrists, UK (2009).
5. Evidence-Based Psychosocial Treatments for Attention-Deficit/Hyperactivity Disorder
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献